Researchers identify new indicator for response to therapy in pediatric cancers
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Researchers identify new indicator for response to therapy in pediatric cancers
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
ASCO 2026: Fasting before and after chemo may help improve treatment response for some people with ovarian cancer
ASCO 2026: Weight loss programme improves physical function, quality of life for patients with breast cancer
ASCO 2026: Less cognitive decline with darolutamide treatment than enzalutamide in people with advanced prostate cancer
Scientists capture ‘housekeeping’ immune cells attacking live melanoma
Researchers identify drivers of resistance to KRAS inhibitors in colorectal cancer
Dermatologists and oncologists call for overhaul of widely used cancer side-effect grading system
ASCO 2026: Genetic clues may reveal which rare solitary fibrous tumours are more aggressive, likely to spread
ASCO 2026: Trial tests virus-immunotherapy combination for neuroendocrine tumours
ASCO 2026: New AI tool may help personalise multiple myeloma treatment
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue